Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Cellular immunosuppression in children with acute lymphoblastic leukemia: Effect of consolidation chemotherapy

  • 67 Accesses

  • 42 Citations

Summary

The present study was designed to evaluate the chemotherapy-induced cellular immunosuppression in 20 children with acute lymphoblastic leukemia (ALL) in remission and receiving maintenance chemotherapy. Peripheral blood was serially obtained from leukemic children during vincristine/cyclophosphamide/6-mercaptopurine/prednisone combined consolidation chemotherapy. The mean absolute number of peripheral blood lymphocytes as well as the mean absolute numbers of lymphocyte subsets (T cells, T cell subsets, B cells, and natural killer cells) from leukemic children before consolidation chemotherapy were all significantly lower than in control subjects; however, the percentages of lymphocyte subsets were similar in both groups. After consolidation chemotherapy, the percentages of CD4+ T lymphocytes and natural killer (NK) cells were significantly decreased and the percentages of monocytes and CD8+ T lymphocytes were significantly increased. Phytohemagglutinin- and 12-O-tetradecanoylphorbol-13-acetate-induced production of interleukin-2 (IL-2) and NK-cell-mediated cytotoxic activity by peripheral blood mononuclear cells (PBMC) were also substantially decreased in the post-therapy groups. NK activity correlated with the percentage of NK cells in PBMC. In contrast, OK432-induced production of tumor necrosis factor α (TNFα) and killer activity against NK-resistant target cells were significantly increased after therapy as compared with the pre-therapy and control groups. TNFα production correlated with the percentage of monocytes in PBMC. These results demonstrate that substantial quantitative and qualitative chemotherapy-induced abnormalities of the cellular immune system are present in the majority of patients treated with ALL. It is also suggested that the increased TNFα production by monocytes and the appearance of potent killing activity against NK-resistant targets might compensate for the defects of IL-2 production and NK activity during intensive consolidation chemotherapy.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Arya SK, Wong-Staar F, Gallo RC (1984) Dexamethasone-mediated inhibition of human T cell growth factor and γ-interferon messenger RNA. J Immunol 133: 273

  2. 2.

    Azuma E, Kaplan J (1988) Role of lymphokine activated killer cells as mediators of veto and natural suppression. J Immunol 142: 2601

  3. 3.

    Beutler B, Krochin N, Milsark IW, Luedke C, Cerami A (1986) Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science 232: 977

  4. 4.

    Borzy MS, Ridgway D (1989) Prolonged defects of interleukin-2 production, responsiveness, and receptor expression in patients with acute lymphoblastic leukemia. Blood 73: 1608

  5. 5.

    Dupont E, Huygen K, Schandene L, Vandercruys M, Palfliet K, Wybran J (1985) Influence of in vivo immunosuppressive drugs on production of lymphokines (1985) Transplantation 39: 143

  6. 6.

    Dupont E, Scandene L, Denys C, Wybran J (1986) Differential in vitro actions of cyclosporin, methylprednisolone, and 6-mercaptopurine: implications for drugs' influence on lymphocyte activation mechanisms. Clin Immunol Immunopathol 40: 422

  7. 7.

    Feldman S, Hughes WT, Kim HY (1973) Herpes zoster in children with cancer. Am J Dis Child 126: 178

  8. 8.

    Grills S, Crabtree GR, Smith KA (1979) Glucocorticoid-induced inhibition of T cell growth factor production: I. The effect on mitogen-induced lymphocyte proliferation. J Immunol 123: 1624

  9. 9.

    Guillou PJ, Giles GR, Ramsden CW (1986) Natural killer-cell activity, interferon-alpha 2 production, and interleukin-2 production on cyclosporin treated and conventionally immunosuppressed human allograft recipients. J Clin Immunol 6: 373

  10. 10.

    Hardy C, Feusner J, Harada S, Sanger W, Von Schmidt B, Yetz J, Saemundsen A, Lennette E, Linder J, Skeeley JK, Lubin B, Purtilo DT (1984) Fetal Epstein-Barr virus-induced lymphoproliferation complicating acute lymphoblastic leukemia. J Pediatr 105: 64

  11. 11.

    Hart PH, Vitti GF, Burgess DR, Whitty GA, Piccoli DS, Hamilton JA (1989) Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor α, interleukin 1, and prostaglandin E2. Proc Natl Acad Sci USA 86: 3803

  12. 12.

    Hayashi H, Kiyota T, Sakamoto H, Seto M (1985) An enzyme-linked immunosorbent assay for recombinant human tumor necrosis factor using monoclonal antibody. In: Seto M, Asahi C (eds) Recent advances in chemotherapy. Tokyo, Japan, p 820

  13. 13.

    Hughes WT, Feldman S, Cox F (1974) Infectious disease in children with cancer. Pediatr Clin North Am 21: 583

  14. 14.

    Ichimura O, Suzuki S, Saito M, Sugawara Y, Ishida N (1985) Augmentation of interleukin 1 and interleukin 2 production by OK-432. Int J Immunopharmacol 7: 263

  15. 15.

    Kaplan MP, Lysz K, Rosenberg SA, Rosenberg JC (1983) Suppression of interleukin-2 production by methylprednisone. Transplant Proc 15: 407

  16. 16.

    Kiyohara T, Taniguchi K, Kubota S, Koga S, Sakurai T, Saitoh Y (1988) Induction of lymphokine-activated killer-like cells by cancer chemotherapy. J Exp Med 168: 2355

  17. 17.

    Lee SW, Tsou A-P, Chan H, Thomas J, Petrie K, Eugui EM, Allison AC (1988) Glucocorticoids selectively inhibit the transcription of the interleukin 1β gene and decrease the stability of interleukin 1β mRNA. Proc Natl Acad Sci USA 85: 1204

  18. 18.

    Mantovani A, Luini W, Peri G, Vecchi A, Spreafico F (1978) Effect of chemotherapeutic agents on natural cell-mediated cytotoxicity in mice. J Natl Cancer Inst 61: 1255

  19. 19.

    Uchiyama T, Hori T, Tsudo M, Wano Y, Umadome H, Tamori S, Yodoi J, Maeda M, Sawami H, Uchino H (1985) Interleukin-2 receptor (Tac antigen) expressed in adult T-cell leukemia cells. J Clin Invest 76: 446

Download references

Author information

Correspondence to Yoshihiro Komada.

Additional information

This work was supported by a grant-in-aid for cancer research from the Ministry of Health and Welfare, Japan, and a grant-in-aid from the Association for the Support of Children with Cancer

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Komada, Y., Zhang, S., Zhou, Y. et al. Cellular immunosuppression in children with acute lymphoblastic leukemia: Effect of consolidation chemotherapy. Cancer Immunol Immunother 35, 271–276 (1992). https://doi.org/10.1007/BF01789334

Download citation

Key words

  • Immunosuppression
  • Chemotherapy
  • Acute lymphoblastic leukemia